NEXA Trademark
Trademark Overview
On Friday, December 23, 2022, a trademark application was filed for NEXA with the United States Patent and Trademark Office. The USPTO has given the NEXA trademark a serial number of 79368445. The federal status of this trademark filing is REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION as of Tuesday, June 25, 2024. This trademark is owned by Cochlear Limited. The NEXA trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Medical Instrument Products categories with the following description:
Downloadable and recorded software for managing clinical data; computer software, recorded for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; downloadable computer programs for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; computer software applications, downloadable for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; all the foregoing for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; none of the foregoing in the field of digital imaging or digital image processing, analysis, measurement, display comparison or simulation of effects of surgical or product treatment outcomes
Pharmaceutical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; medical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; pharmaceutical drugs, namely, pharmaceutical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; corticosteroids; steroids, namely, dexamethasone; anti-inflammatory drugs; chemical reagents for medical purposes; chemical preparations for medical purposes, for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; all the foregoing for or in relation to the inner ear or auditory system of a human
Medical devices, namely, hearing aids, cochlear implants made from artificial materials and in-ear monitors for medical purposes, components of medical devices, namely, sound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; prosthetic hearing devices and components of prosthetic hearing devices, namely, hearing aids, sound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; accessories for use with prosthetic hearing devices, namely, wireless transmitters and receivers for use with hearing aids; medical implants, namely, an implanted hearing device in the nature of a cochlear implant made from artificial materials, for delivering pharmaceutical preparations, medical preparations, pharmaceutical drugs, corticosteroids, dexamethasone, anti-inflammatory drugs, chemical reagents, or chemical preparations to the inner ear or auditory system of a human
General Information
Serial Number | 79368445 |
Word Mark | NEXA |
Filing Date | Friday, December 23, 2022 |
Status | 802 - REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION |
Status Date | Tuesday, June 25, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, June 18, 2024 |
Trademark Statements
Goods and Services | Downloadable and recorded software for managing clinical data; computer software, recorded for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; downloadable computer programs for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; computer software applications, downloadable for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; all the foregoing for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; none of the foregoing in the field of digital imaging or digital image processing, analysis, measurement, display comparison or simulation of effects of surgical or product treatment outcomes |
Goods and Services | Pharmaceutical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; medical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; pharmaceutical drugs, namely, pharmaceutical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; corticosteroids; steroids, namely, dexamethasone; anti-inflammatory drugs; chemical reagents for medical purposes; chemical preparations for medical purposes, for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; all the foregoing for or in relation to the inner ear or auditory system of a human |
Goods and Services | Medical devices, namely, hearing aids, cochlear implants made from artificial materials and in-ear monitors for medical purposes, components of medical devices, namely, sound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; prosthetic hearing devices and components of prosthetic hearing devices, namely, hearing aids, sound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; accessories for use with prosthetic hearing devices, namely, wireless transmitters and receivers for use with hearing aids; medical implants, namely, an implanted hearing device in the nature of a cochlear implant made from artificial materials, for delivering pharmaceutical preparations, medical preparations, pharmaceutical drugs, corticosteroids, dexamethasone, anti-inflammatory drugs, chemical reagents, or chemical preparations to the inner ear or auditory system of a human |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 28, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 28, 2023 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 28, 2023 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Cochlear Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 83 - NOT AVAILABLE |
Address | AU |
Party Name | Cochlear Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 83 - NOT AVAILABLE |
Address | AU |
Trademark Events
Event Date | Event Description |
Thursday, April 27, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Tuesday, May 2, 2023 | APPLICATION FILING RECEIPT MAILED |
Sunday, September 24, 2023 | ASSIGNED TO EXAMINER |
Friday, April 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, September 26, 2023 | NON-FINAL ACTION WRITTEN |
Wednesday, November 1, 2023 | REFUSAL PROCESSED BY IB |
Wednesday, September 27, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Friday, October 6, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Friday, October 6, 2023 | REFUSAL PROCESSED BY MPU |
Monday, April 8, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, April 8, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, April 8, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, April 20, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Saturday, April 20, 2024 | FINAL REFUSAL E-MAILED |
Saturday, April 20, 2024 | FINAL REFUSAL WRITTEN |
Thursday, May 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, May 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, May 2, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Tuesday, May 14, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, May 14, 2024 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, May 14, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, May 14, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Tuesday, May 14, 2024 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, May 29, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, June 11, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Tuesday, June 11, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Tuesday, June 25, 2024 | EXTENSION OF TIME TO OPPOSE RECEIVED |
Tuesday, June 18, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 18, 2024 | PUBLISHED FOR OPPOSITION |